Delay in the diagnosis and treatment of tuberculosis in prisons in Mato Grosso do Sul, Brazil.
Journal
Revista da Sociedade Brasileira de Medicina Tropical
ISSN: 1678-9849
Titre abrégé: Rev Soc Bras Med Trop
Pays: Brazil
ID NLM: 7507456
Informations de publication
Date de publication:
2023
2023
Historique:
received:
09
01
2023
accepted:
26
05
2023
medline:
27
7
2023
pubmed:
26
7
2023
entrez:
26
7
2023
Statut:
epublish
Résumé
The number of tuberculosis (TB) cases in prisons is higher than that in the general population and has been reported as the most common cause of death in prisons. This study evaluated the delay in the diagnosis and treatment of TB in Brazilian prisons. A retrospective cohort study was conducted between 2007 and 2015 using data from the five largest male prisons in Mato Grosso do Sul, Brazil. TB case data was collected from the National Database of Notifiable Diseases (SINAN), GAL-LACEN, and prison medical records. The following variables were recorded: prison, year of diagnosis, age, race, education, HIV status, smoking status, comorbidities, number of symptoms, percentage of cures, delay in diagnosis, patient delay, provider delay, laboratory delay, and delay in treatment. Descriptive statistics were used for the variables of interest. A total of 362 pulmonary TB cases were identified. The average time between the first symptom and reporting of data was 94 days. The mean time between symptom onset and laboratory diagnosis was 91 days. The average time from symptom onset to first consultation was 80 days. The time between diagnosis and treatment initiation was 5 days. Delays were significant between reporting of the first symptoms and diagnosis and significantly smaller from the time between notification and start of treatment. Control strategies should be implemented to diagnose cases through active screening, to avoid delays in diagnosis and treatment, and to reduce TB transmission.
Sections du résumé
BACKGROUND
BACKGROUND
The number of tuberculosis (TB) cases in prisons is higher than that in the general population and has been reported as the most common cause of death in prisons. This study evaluated the delay in the diagnosis and treatment of TB in Brazilian prisons.
METHODS
METHODS
A retrospective cohort study was conducted between 2007 and 2015 using data from the five largest male prisons in Mato Grosso do Sul, Brazil. TB case data was collected from the National Database of Notifiable Diseases (SINAN), GAL-LACEN, and prison medical records. The following variables were recorded: prison, year of diagnosis, age, race, education, HIV status, smoking status, comorbidities, number of symptoms, percentage of cures, delay in diagnosis, patient delay, provider delay, laboratory delay, and delay in treatment. Descriptive statistics were used for the variables of interest.
RESULTS
RESULTS
A total of 362 pulmonary TB cases were identified. The average time between the first symptom and reporting of data was 94 days. The mean time between symptom onset and laboratory diagnosis was 91 days. The average time from symptom onset to first consultation was 80 days. The time between diagnosis and treatment initiation was 5 days.
CONCLUSIONS
CONCLUSIONS
Delays were significant between reporting of the first symptoms and diagnosis and significantly smaller from the time between notification and start of treatment. Control strategies should be implemented to diagnose cases through active screening, to avoid delays in diagnosis and treatment, and to reduce TB transmission.
Identifiants
pubmed: 37493729
pii: S0037-86822023000100322
doi: 10.1590/0037-8682-0015-2023
pmc: PMC10367220
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e00152023Références
J Bras Pneumol. 2011 Jul-Aug;37(4):512-20
pubmed: 21881742
Rev Panam Salud Publica. 2019 Jan 04;43:e16
pubmed: 31093240
BMC Public Health. 2004 May 29;4:18
pubmed: 15169548
BMC Public Health. 2002 Sep 25;2:23
pubmed: 12296975
Health Policy Plan. 2007 Sep;22(5):329-34
pubmed: 17698889
BMC Infect Dis. 2015 Jan 22;15:24
pubmed: 25608746
Eur Respir J. 2008 Nov;32(5):1415-6
pubmed: 18978146
BMC Infect Dis. 2016 Oct 3;16(1):533
pubmed: 27716170
BMC Pulm Med. 2018 May 2;18(1):64
pubmed: 29716569
PLoS Med. 2010 Dec 21;7(12):e1000381
pubmed: 21203587
Cien Saude Colet. 2016 Jun;21(7):2147-60
pubmed: 27383348
BMC Infect Dis. 2009 Jun 11;9:91
pubmed: 19519917
PLoS Med. 2019 Jan 24;16(1):e1002737
pubmed: 30677013
Emerg Infect Dis. 2015 Mar;21(3):452-5
pubmed: 25642998